Two Sigma Advisers’s Aethlon Medical AEMD Stock Holding History

Two Sigma Advisers’s Portfolio AEMD Stock Details AEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-43	Closed	-$13.2K	–	2365
2023 Q1	$13.2K	Buy	+43	New	+$16.2K	﹤0.01%	2533
2022 Q4	–	Sell	-17	Closed	-$8K	–	2499
2022 Q3	$8K	Buy	+17	New	+$14.7K	﹤0.01%	2488
2022 Q1	–	Sell	-53	Closed	-$79K	–	2716
2021 Q4	$79K	Buy	+53	New	+$121K	﹤0.01%	2434

Other funds holding AEMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

AFGAS

Allegiance Financial Group Advisory Services Vienna, Virginia $503M AUM 22.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Two Sigma Advisers's AEMD Position: Q2 2023 in Review

Two Sigma Advisers sold out of Aethlon Medical (AEMD) in Q2 2023, closing a stake of 43 shares — an estimated $13.2K sold.

Two Sigma Advisers first reported a position in AEMD in Q4 2021 and held it in 3 quarters. The position peaked at $79K in Q4 2021. 22 funds tracked by Wall St. Rank hold AEMD as of Q2 2023.

Two Sigma Advisers reported no remaining Aethlon Medical position as of Q2 2023 after selling out during the quarter.
Two Sigma Advisers sold 43 Aethlon Medical shares in Q2 2023, an estimated $13.2K.
Two Sigma Advisers first reported a position in Aethlon Medical in Q4 2021 and held it in 3 quarters.
Two Sigma Advisers's Aethlon Medical position peaked at $79K in Q4 2021.
22 funds tracked by Wall St. Rank held Aethlon Medical as of Q2 2023.

Based on Two Sigma Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.